Nucleotide excision repair gene polymorphisms, meat intake and colon cancer risk

Susan E Steck1, Lesley M Butler2, Temitope Keku3

  • 1Department of Epidemiology and Biostatistics, Cancer Prevention and Control Program, Arnold School of Public Health, University of South Carolina, 915 Greene Street, RM 236, Columbia, SC 29208, USA.

Mutation Research
|March 11, 2014
PubMed
Abstract

Insights

Genetic variations in nucleotide excision repair (NER) influence colon cancer risk. Specific NER gene variants, like XPC, modify the association between red meat consumption and cancer development.

Area of Science:

  • Genetics
  • Cancer Research
  • Molecular Epidemiology

Background:

  • Colon cancer is linked to carcinogens in red meat, such as heterocyclic amines (HCAs) and polycyclic aromatic hydrocarbons (PAHs).
  • The nucleotide excision repair (NER) pathway is crucial for repairing DNA damage caused by these carcinogens.
  • Non-synonymous single nucleotide polymorphisms (nsSNPs) in NER genes may alter DNA repair efficiency and influence cancer susceptibility.

Purpose of the Study:

  • To investigate whether nsSNPs in NER genes modify the association between red meat intake and colon cancer risk.
  • To identify specific NER gene variants that impact susceptibility to colon cancer.

Main Methods:

  • A case-control study involving 244 African-American and 311 white colon cancer cases and their controls.
  • Dietary intake of HCAs and benzo(a)pyrene (BaP) was estimated using food frequency questionnaires.
  • Seven nsSNPs in five NER genes (XPC, XPD, XPF, XPG, RAD23B) were genotyped and analyzed for association with colon cancer risk.

Main Results:

  • Among African Americans, specific XPC genotypes (A499V and K939Q) showed significant associations with colon cancer risk.
  • These associations were not observed in the white population.
  • A significant interaction was found between XPC 939 genotype, well-done red meat intake, and colon cancer risk in the combined population.

Conclusions:

  • NER nsSNPs are associated with colon cancer risk.
  • These genetic variations may modify the link between consuming well-done red meat and developing colon cancer.
  • Findings highlight the role of DNA repair gene polymorphisms in cancer etiology.

Related Concept Videos

Nucleotide Excision Repair01:38

Nucleotide Excision Repair

DNA Distortion and Damage
Cells are regularly exposed to mutagens—factors in the environment that can damage DNA and generate mutations. UV radiation is one of the most common mutagens and is estimated to introduce a significant number of changes in DNA. These include bends or kinks in the structure, which can block DNA replication or transcription. If these errors are not fixed, the damage can cause mutations, which in turn can result in cancer or disease depending on which sequences are...
4.6K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

Overview
33.7K
Nucleotide Excision Repair01:08

Nucleotide Excision Repair

10.9K
Base Excision Repair01:54

Base Excision Repair

One of the common DNA damages is the chemical alteration of single bases by alkylation, oxidation, or deamination. The altered bases cause mispairing and strand breakage during replication. This type of damage causes minimal change to the DNA double helix structure and can be repaired by the base excision repair (BER) pathways. BER corrects damaged DNA sequences by removing the damaged base and restoring the original base sequence using the complementary strand as a template.
The first step of...
20.3K
Base Excision Repair01:54

Base Excision Repair

4.3K
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
81